Rankings
▼
Calendar
SYRE FY 2023 Earnings — Spyre Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SYRE
Spyre Therapeutics, Inc.
$3B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$886,000
-62.0% YoY
Gross Profit
$886,000
100.0% margin
Operating Income
-$242M
-27348.0% margin
Net Income
-$339M
-38238.1% margin
EPS (Diluted)
$-46.15
Cash Flow
Operating Cash Flow
-$100M
Free Cash Flow
-$100M
Stock-Based Comp.
$26M
Balance Sheet
Total Assets
$342M
Total Liabilities
$158M
Stockholders' Equity
$184M
Cash & Equivalents
$189M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$886,000
$2M
-62.0%
Gross Profit
$886,000
$2M
-62.0%
Operating Income
-$242M
-$85M
-185.8%
Net Income
-$339M
-$84M
-304.2%
← Q4 2022
All Quarters
Q1 2023 →